Logo image of FATH

FATHOM DIGITAL MANUFACTURING (FATH) Stock Fundamental Analysis

NYSE:FATH - New York Stock Exchange, Inc. - US31189Y2028 - Common Stock - Currency: USD

5.05  -0.22 (-4.17%)

Fundamental Rating

2

Taking everything into account, FATH scores 2 out of 10 in our fundamental rating. FATH was compared to 127 industry peers in the Machinery industry. FATH has a bad profitability rating. Also its financial health evaluation is rather negative. FATH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

FATH had negative earnings in the past year.
FATH had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: FATH reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: FATH reported negative operating cash flow in multiple years.
FATH Yearly Net Income VS EBIT VS OCF VS FCFFATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -100M -200M -300M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.87%, FATH is in line with its industry, outperforming 56.92% of the companies in the same industry.
Looking at the Return On Equity, with a value of 22.14%, FATH belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
ROA 4.87%
ROE 22.14%
ROIC N/A
ROA(3y)-41.95%
ROA(5y)-26.99%
ROE(3y)-378.05%
ROE(5y)-230.36%
ROIC(3y)N/A
ROIC(5y)N/A
FATH Yearly ROA, ROE, ROICFATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

The Profit Margin of FATH (12.23%) is better than 82.31% of its industry peers.
With a Gross Margin value of 28.70%, FATH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
FATH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 12.23%
GM 28.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.55%
GM growth 5YN/A
FATH Yearly Profit, Operating, Gross MarginsFATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

FATH does not have a ROIC to compare to the WACC, probably because it is not profitable.
FATH has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, FATH has a worse debt to assets ratio.
FATH Yearly Shares OutstandingFATH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M
FATH Yearly Total Debt VS Total AssetsFATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -2.43, we must say that FATH is in the distress zone and has some risk of bankruptcy.
FATH has a Altman-Z score of -2.43. This is amonst the worse of the industry: FATH underperforms 85.38% of its industry peers.
FATH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.03, FATH belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.43
ROIC/WACCN/A
WACC8.6%
FATH Yearly LT Debt VS Equity VS FCFFATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.22 indicates that FATH may have some problems paying its short term obligations.
FATH has a Current ratio of 0.22. This is amonst the worse of the industry: FATH underperforms 97.69% of its industry peers.
A Quick Ratio of 0.16 indicates that FATH may have some problems paying its short term obligations.
FATH has a worse Quick ratio (0.16) than 96.92% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.16
FATH Yearly Current Assets VS Current LiabilitesFATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.40% over the past year.
Looking at the last year, FATH shows a very negative growth in Revenue. The Revenue has decreased by -18.50% in the last year.
FATH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.90% yearly.
EPS 1Y (TTM)101.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.25%
Revenue 1Y (TTM)-18.5%
Revenue growth 3Y28.9%
Revenue growth 5YN/A
Sales Q2Q%-16.6%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
Based on estimates for the next years, FATH will show a quite strong growth in Revenue. The Revenue will grow by 12.36% on average per year.
EPS Next Y-71.29%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.3%
Revenue Next 2Y12.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
FATH Yearly Revenue VS EstimatesFATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
FATH Yearly EPS VS EstimatesFATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 -2 -4 -6 -8

1

4. Valuation

4.1 Price/Earnings Ratio

FATH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FATH Price Earnings VS Forward Price EarningsFATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

FATH's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. FATH is more expensive than 71.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.92
FATH Per share dataFATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

FATH's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FATH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FATHOM DIGITAL MANUFACTURING

NYSE:FATH (5/20/2024, 8:04:01 PM)

5.05

-0.22 (-4.17%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2024-05-15/amc
Earnings (Next)08-12 2024-08-12/bmo
Inst Owners0.09%
Inst Owner Change0%
Ins Owners70.19%
Ins Owner Change0%
Market Cap34.69M
Analysts45.71
Price Target4.85 (-3.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.58%
Min EPS beat(2)-100%
Max EPS beat(2)46.85%
EPS beat(4)3
Avg EPS beat(4)-2.37%
Min EPS beat(4)-100%
Max EPS beat(4)46.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-5.06%
Max Revenue beat(2)-4.2%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)5.13%
Revenue beat(8)2
Avg Revenue beat(8)-2.34%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 0.48
P/tB N/A
EV/EBITDA 27.92
EPS(TTM)-6.68
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS19.11
BVpS10.56
TBVpS-23.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.87%
ROE 22.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 12.23%
GM 28.7%
FCFM N/A
ROA(3y)-41.95%
ROA(5y)-26.99%
ROE(3y)-378.05%
ROE(5y)-230.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.55%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.28
Cap/Depr 19.86%
Cap/Sales 3.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.16
Altman-Z -2.43
F-Score3
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)42.27%
Cap/Depr(5y)35.26%
Cap/Sales(3y)5.96%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.25%
EPS Next Y-71.29%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.5%
Revenue growth 3Y28.9%
Revenue growth 5YN/A
Sales Q2Q%-16.6%
Revenue Next Year-1.3%
Revenue Next 2Y12.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-153.47%
OCF growth 3YN/A
OCF growth 5YN/A